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The incidence of obesity is steadily increasing, and its
prevalence, defined as a body mass index (BMI) above
30 kg/m2, is 13% in the world adult population, and rises
to up to 40% in high-income countries [1]. As a conse-
quence, around 20% of the patients admitted to the in-
tensive care unit (ICU) are obese [2]. Obesity and
overweight are associated with an increased risk of death
in the general population [3], but in specific disease con-
ditions a decrease in mortality has been reported: this is
the case of patients with septic shock [4] and acute re-
spiratory distress syndrome (ARDS), and is referred to
as the obesity paradox. The association between higher
BMI and lower mortality is difficult to interpret and po-
tentially influenced by several confounding factors. In
patients with ARDS, this paradox is particularly surpris-
ing, as obese patients have peculiar alterations of the re-
spiratory function, such as increased chest wall elastance
and lower total respiratory system compliance, posing
specific challenges for the clinician when mechanical
ventilation is required [5, 6].
The obesity paradox in ARDS patients has been inves-
tigated in several studies and two recent meta-analyses
[7, 8]. Ni and co-authors [7] analysed the evidence con-
cerning the association between BMI and clinical out-
comes in ARDS patients, pooling data from 6268
patients enrolled in five studies, including three pro-
spective observational studies [9–11], a retrospective co-
hort study [12] and one randomised controlled trial [13].
The authors conclude that obesity and morbid obesity
were associated with a lower mortality rate in patients
with ARDS, therefore supporting the concept of the
obesity paradox. In another recent analysis including
four additional studies, Zhi et al. [8] reported that obes-
ity increased ARDS-associated morbidity in the ICU
population; however, mortality due to ARDS in obese
was lower compared to non-obese patients. An in-
creased mortality among underweight patients was also
reported, which could be explained by the worse clinical
conditions and comorbidities of patients admitted to the
ICU with impaired nutritional status.
In the five studies included by Ni et al., [7] obese pa-
tients were systematically younger and had lower severity
scores compared to the reference group (normal weight),
while the opposite was observed in the underweight pa-
tients. The analysis by Zhi et al. [8] does not report pa-
tients’ severity scores. Figure 1 illustrates the observed
unadjusted mortality rates in the different obesity classes
for the studies included in the meta-analyses for which se-
verity scores (SAPS II predicted mortality or APACHE III)
could be extracted: the trend in mortality in the different
obesity classes is similar to that of illness severity. This
could suggest that the effect of BMI on mortality might be
mediated by other clinical factors.
Both meta-analyses present some limitations: 1) inclu-
sion of retrospective studies; 2) lack of adjustment for
confounders; 3) most analyses are restricted to studies in
which obesity was classified according to the WHO BMI
classes; and 4) the presence of heterogeneity in some ana-
lyses. The adjustment for potential confounding factors is
virtually impossible in a conventional meta-analysis with-
out access to individual patient data, especially when a
limited number of studies is included [14]. Indeed, when
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correcting for confounders, BMI was no longer associated
with mortality in one of the studies [10], as previously re-
ported in mechanically ventilated patients [15].
Several pathophysiological mechanisms and clinical
management-related factors could explain the decreased
mortality in obese critically ill patients, including those
with ARDS. Recent evidence suggests the existence of a
protective response called pre-conditioning cloud where
obesity induces a low-grade inflammation, generating a
process that subsequently protects the lung against further
insults [16]. Indeed, pre-conditioning implies that a
chronic pro-inflammatory status creates a protective en-
vironment, limiting the detrimental effects of a more ag-
gressive second hit, such as ventilator-induced lung injury
or sepsis. Obesity itself increases the plasma and adipose
levels of inflammatory cytokines, including in ARDS [13],
and the adipose-triggered inflammatory mediators could
alter peripherally the physiological responses to injury,
contributing to abnormalities in systemic and pulmonary
circulation [17]. Some of these mechanisms are similar to
the endogenous reactive protection occurring during
endotoxemia in healthy subjects [18]. Also, during crit-
ical illness adipose tissue macrophages shift from pro-
inflammatory M1 to alternative or anti-inflammatory
M2 phenotypes [19]. Finally, the concept of meta-
bolically healthy obesity (MHO) has been recently
proposed, referring to obese individuals without asso-
ciated metabolic comorbidities [20]. Interestingly,
MHO has been linked to weaker adipose-related in-
flammatory activity and lower mortality risk compared
to individuals with metabolically unhealthy obesity
[20]. Moreover, clinicians tend to consider obese pa-
tients at high risk of worse outcome; thus, this
might result in earlier admission to the ICU for
monitoring purposes as well as increased use of
prophylactic measures such as early mobilisation,
more cautious pressure ulcer prevention, stricter gly-
caemic control, and more attention paid to mechan-
ical ventilation parameters [21]. Moreover, in obesity,
the high chest wall elastance could redistribute re-
gional transpulmonary pressure, possibly reducing the
potential negative effects of mechanical ventilation in an
inhomogeneous lung.
Meta-analyses of observational studies are a tool for
generating experimental hypotheses to be tested in other
experimental settings, and their results should be cau-
tiously interpreted as an association, not necessarily im-
plying causality. It would be extremely important to
answer the question of whether the obesity paradox in
ARDS is mediated by other factors: if the association is
confirmed it could open new perspectives for the man-
agement of respiratory failure. A quasi-experimental set-
ting could be achieved by performing an individual data
meta-analysis, but further physiological and clinical
studies are warranted to better understand the inter-
action between obesity and response to critical illness.
Fig. 1 Mortality and disease severity in different BMI classes. Upper panel: unadjusted observed mortality rates in the five BMI classes. Lower panel:
APACHE III severity scores. For one study [9] the APACHE III score was not reported; therefore, the SAPS II predicted mortality is plotted (blue
dashed line). This figure reports data from only the studies included in the two meta-analyses [14, 15] for which disease severity was available.
O’Brien 2006 [9], Morris 2007 [11], Stapleton 2010 [13], Soto 2012 [12], Gong 2010 [10], Soubani 2015 [22]
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